ConductScience.org, home

Paper7326201

Biochemical effects of vindesine.

Creasey WA. Br J Cancer, 1981. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Biochemical effects of vindesine. Papers, record 7326201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7326201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biochemical effects of vindesine.
PubMed
Journal
Br J Cancer
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2019-05-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Creasey WAW A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
Sarcoma, ExperimentalMajor topic
VinblastineMajor topic
Animals
DNA, Neoplasm
Lipids
Mice
Mice, Inbred Strains
Neoplasm Proteins
RNA, Neoplasm
Vindesine

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
14489PHS HHSUnited StatesPubMed
16520PHS HHSUnited StatesPubMed
23147PHS HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15893003Biochemical effects of the vinca alkaloids. 3. The synthesis of ribonucleic acid and the incorporation of amino acids in Ehrlich ascites cells in vitro.Biochim Biophys Acta1965https://conductscience.org/library/papers/5893003PubMed
24290650[The effect of vincaleukoblastine (Velbe) on the glycolysis of tumor cells].Eur J Cancer (1965)1966https://conductscience.org/library/papers/4290650PubMed
35780988Biochemical effects of the Vinca alkaloids. IV. Studies with vinleurosine.Biochem Pharmacol1969https://conductscience.org/library/papers/5780988PubMed
41260766Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.Cancer Res1976https://conductscience.org/library/papers/1260766PubMed
514078917EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN.Biochem Pharmacol1963https://conductscience.org/library/papers/14078917PubMed
6134714Biochemical effects of d-tetrandrine and thalicarpine.Biochem Pharmacol1976https://conductscience.org/library/papers/134714PubMed
7872088Pharmacokinetics of vindesine and vincristine in humans.Cancer Res1977https://conductscience.org/library/papers/872088PubMed
8329987Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).Cancer Treat Rev1977https://conductscience.org/library/papers/329987PubMed
9945741Effects of adriamycin on surface properties of sarcoma 180 ascites cells.Biochem Pharmacol1976https://conductscience.org/library/papers/945741PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7326201

GET https://conductscience.org/api/papers/v1/7326201/authors